Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2337/diacare.25.10.1888-a | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Burden of Pulmonary Hypertension in End-Stage Renal Disease Patients Receiving Maintenance Hemodialysis: Evaluation Factors and Treatment Strategies.
Cureus
September 2024
Community and Family Medicine, All India Institutes of Medical Sciences, Madurai, Madurai, IND.
Background Chronic kidney disease (CKD) is an emerging public health problem in India. Pulmonary hypertension (PH) is an overlooked cardiovascular complication of CKD. This study aimed to estimate the burden of PH among CKD patients undergoing hemodialysis in a selected tertiary care hospital.
View Article and Find Full Text PDFIncreased cGMP improves microvascular exercise training adaptations independent of endothelial nitric oxide synthase.
bioRxiv
September 2024
Department of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, Tennessee, USA.
Article Synopsis
- * Researchers investigated the effects of the PDE-5a inhibitor sildenafil and found that it enhances the benefits of exercise by improving microcirculation and exercise capacity in diet-induced obese mice, but not in sedentary mice.
- * In lean mice with reduced endothelial nitric oxide synthase (eNOS), exercise training still improved endurance, indicating that while eNOS function is important, training alone can lead to significant benefits in microcirculation and exercise performance.
Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K/AKT/mTOR signaling pathway to improve diabetic erectile dysfunction.
PLoS One
September 2024
Urology Department of General Hospital, Ningxia Medical University, Ningxia, China.
Objective: This study aims to explore the impact of Nesfatin-1 on type 2 diabetic erectile dysfunction (T2DMED) and its underlying mechanism in regulating the phenotypic switching of corpus cavernosum smooth muscle cells (CCSMCs).
Methods: Twenty-four 4-week-old male C57 wild-type mice were randomly assigned to the control group, model group, and Nesfatin-1 treatment group. Monitoring included body weight, blood glucose levels, and penile cavernous pressure (ICP).
Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K/AKT/mTOR signaling pathway to improve diabetic erectile dysfunction.
Heliyon
July 2024
Urology Department of General Hospital, Ningxia Medical University, Ningxia 750000, China.
Objective: This study aims to explore the impact of Nesfatin-1 on type 2 diabetic erectile dysfunction (T2DMED) and its underlying mechanism in regulating the phenotypic switching of corpus cavernosum smooth muscle cells (CCSMCs).
Methods: Twenty-four 4-week-old male C57 wild-type mice were randomly assigned to the control group, model group, and Nesfatin-1 treatment group. Monitoring included body weight, blood glucose levels, and penile cavernous pressure (ICP).
Risk Factors and Mortality in Newborns with Persistent Pulmonary Hypertension: A Six-Year Single-Center Experience.
Sisli Etfal Hastan Tip Bul
June 2024
Neonatal Intensive Care Unit, University of Health Sciences Türkiye, Umraniye Training and Research Hospital, Istanbul, Türkiye.
Objectives: Persistent pulmonary hypertension (PPHT) of the newborn is a disorder of circulatory transition resulting in high pulmonary vascular resistance with extrapulmonary right-to-left shunts causing hypoxemia. In this study, our aim was to evaluate the risk factors, administered treatments, and mortality of patients followed in our neonatal intensive care unit (NICU) due to PPHT over the past six years.
Methods: Patients diagnosed with PPHT and followed in the NICU between January 2017 and November 2022 were included in the study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!